Now showing items 73-89 of 89

      Funding
      OXION programme of the Wellcome Trust [1]
      PADRE / ERA-NET Neuron [1]
      PADRE Pharmakogenetische Einflüsse auf das Ansprechen von Antidepressiva: Potenziell prädiktive Biomarker für das Therapieansprechen aus Experimenten an menschlichen lymphoblastoiden Zelllinien / BMBF ERA-Net NEURON [01EW1108] [1]
      Robert Koch-Institut (RKI) [1]
      Robert‐Koch‐Institute (RKI) [1]
      Sanofi Aventis [1]
      SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / SFB / 217328187 [1]
      SFB 1074 Teilprojekt A04 / Analyse der Funktion des "Lymphoid enhancer-binding factor 1" (Lef1) in der Pathogenese der akuten myeloischen Leukämie / DFG / SFB / 217328187 [1]
      SFB 1149 Teilprojekt B03 / Hyperoxie nach Schädel-Hirn-Trauma und hämorrhagischem Schock bei Atherosklerose / DFG / SFB / 251293561 [1]
      Sir Henry Wellcome Postdoctoral Fellowship of the Wellcome Trust [098896] [1]
      Stiefel, a GSK company [1]
      Therapiekontrolle bei M. Parkinson / MWK Baden-Württemberg [Az: 33-7533-7-11.6-10/2] [1]
      This research was funded by the German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF) due to a decision of the German Bundestag. It was part of the research project 18239 N by the Association for Research in Precision Mechanics, Optics and Medical Technology (F.O.M.) under the auspices of the German Federation of Industrial Research Associations (AiF). [1]
      Ulm University [1]
      Vertragsforschungsvorhaben AZ E/U2AD/CF523/DF556 / Bundesministerium der Verteidigung [1]
      Wellcome Investigator Award [1]
      Wellcome Trust [WT098395/Z/12/Z] [1]